126062-63-3

Usage

Uses

Used in Organic Synthesis:
3-Bromomethyl-benzoic acid tert-butyl ester is used as a building block for the synthesis of various organic compounds. Its unique structure allows for the formation of new chemical bonds and the creation of a wide range of organic molecules.
Used in Pharmaceutical Research:
3-Bromomethyl-benzoic acid tert-butyl ester is used as a reagent in the production of pharmaceutical products. Its versatility and reactivity make it a valuable component in the development of new drugs and medications.
Used in Fragrance and Flavor Industry:
3-Bromomethyl-benzoic acid tert-butyl ester is used as an intermediate in the manufacture of fragrances and flavors. Its ability to react with other compounds allows for the creation of unique and complex scents and tastes.
Used in Agricultural Chemicals:
3-Bromomethyl-benzoic acid tert-butyl ester is used as an intermediate in the production of agricultural chemicals. Its chemical properties make it suitable for use in the development of pesticides, herbicides, and other agricultural products.

Upstream product

• 16537-19-2 tert-butyl m-methylbenzoate 
• 6515-58-8 3-bromomethylbenzoic acid 
• 98946-18-0 tert-Butyl 2,2,2-trichloroacetimidate 
• 209743-33-9 3-(bromomethyl)benzoyl bromide 
• 865-47-4 potassium tert-butylate 
• 99-04-7 m-Toluic acid 

Downstream Products

• 126062-62-2 (3-tert-Butoxycarbonyl-benzyl)-dimethyl-trimethylsilanylmethyl-ammonium; bromide 
• 126082-42-6 4-Dimethylaminomethyl-3-methyl-benzoic acid tert-butyl ester 
• 126062-77-9 2-Dimethylaminomethyl-3-methyl-benzoic acid tert-butyl ester 
• 126062-74-6 6-Dimethylaminomethyl-5-methylene-cyclohexa-1,3-dienecarboxylic acid tert-butyl ester 
• 215522-96-6 3-hydroxymethyl-benzoic acid tert-butyl ester 
• 1326778-92-0 C₃₇H₄₉N₃O₄ 
• 1326778-94-2 C₂₄H₃₂N₂O₃ 
• 1326778-95-3 C₃₄H₄₃N₃O₄ 
• 1326778-97-5 C₂₂H₂₈N₂O₃ 
• 1326778-98-6 C₃₁H₃₇N₃O₄ 
• 1326779-00-3 C₂₈H₄₀N₂O₃ 
• 1326779-01-4 C₄₀H₅₅N₃O₄ 
• 1326779-04-7 C₄₄H₅₃N₃O₅ 
• 1326779-10-5 C₇₇H₉₂N₆O₈ 

Relevant academic research and scientific papers

A class of GPR40 agonist compounds with amide structure, and uses thereof

The present invention relates to a class of amide compounds with a novel structure, and a pharmaceutical composition thereof, wherein the structure of the amide compound is represented by a general formula (I). According to the present invention, the amide compound (I) can regulate GPR40 activity, and can be used for GPR40 activity related diseases such as diabetes and metabolic syndrome. The formula I is defined in the specification.

Synthesis, antibacterial activity, and docking studies of some new 2-substituted-1,8-naphthyridine derivatives

1,8-Naphthyridine derivatives play a very important role in the field of medicinal chemistry. 2 series of novel 2-substituted-1,8-naphthyridine derivatives (10a-10k and 15a-15e) were synthesized. All the synthesized compounds were characterized by1H nuclear magnetic resonance (NMR),13C NMR, mass, and IR spectral analysis. Further, these compounds were evaluated for their antibacterial activity. Docking studies for these title compounds are also presented in this communication.

PYRIMIDINONE DERIVATIVE HAVING AUTOTAXIN-INHIBITORY ACTIVITY

A compound according to any one of formula (Ia) to (Ic), or its pharmaceutically acceptable salt: wherein R1, R2, R3, R4a, R4c, R5 are as defined in the description.

Expedient solution-phase synthesis and NMR studies of arylopeptoids

The development of a highly convenient and efficient protocol for iterative solution-phase synthesis of shorter oligomers of para-and meta-arylopeptoids is described. Peptide coupling methods for accessing longer oligomers were studied: use of the new cou

NITROGEN-CONTAINING HETEROARYL DERIVATIVES

Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections.

Parallel synthesis of glycomimetic libraries: targeting a C-type lectin.

We have developed methods for the parallel synthesis of two libraries of non-carbohydrate-based analogues of mannose on a solid support. The natural product shikimic acid was used as a key building block. The ability of the compounds to block the binding of the C-type lectin MBP-A to a mannosylated surface was assessed in a high-throughput assay. Ten library members with inhibitory activities equivalent to that of alpha-methyl mannopyranoside were identified. [reaction: see text]

Protease inhibitors

The present invention provides compounds of formula (I) which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia or malignancy; and metabolic bone disease therewith.

Pyrimidin derivatives

The invention relates to new pharmaceutically active compounds which are are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.

Analogs of tyrosine sulfate or tyrosine phosphate containing peptides

Analogs of Tyrosine Sulfate or Tyrosine Phosphate containing peptides, the novel intermediate compounds used in the preparation of these analogs, as well as a method for suppressing appetite in subjects by administering to the subject an effective amount